Global Treatment Planning Software Market

Treatment Planning Software Comprehensive Study by Type (Auto-contouring Software, Multi-modality Software, PET/CT Deformable Software, DICOM-RT Software), End User (Hospitals, Cancer Research Institute, Diagnostic & Treatment Centers) Players and Region - Global Market Outlook to 2026

Treatment Planning Software Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Treatment Planning Software Market Overview:
The treatment planning software market is being driven by rising demand for innovative and successful cancer therapies around the world, as well as a rise in the number of cancer patients and their large spending budgets. Furthermore, the fact that the software is more reliable, quick, and effective, and provides advanced treatment with the aid of beam planning and automated calculations, propels market growth during the forecast period.

Growth Drivers
  • Increase in the Number of Cancer Patients and a Sizable Expenditure Budget of Them
  • Rising Demand for the Effective and More Advanced Cancer Treatment

Market Trends
  • Continues Advancements in the Software

Roadblocks
  • High Cost of the Software

Opportunities
  • Increasing Popularity of the Proton Therapy for the Radiation Therapy
  • High Demand from Emerging Market

Challenges
  • Lack of Skilled Workforce to Plan and Operate the Software


Competitive Landscape:
Treatment planning software market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions across the globe.
Some of the key players profiled in the report are DOSIsoft SA (France), MIM Software Inc. (United States), RaySearch Laboratories (Sweden), Elekta AB (Sweden), Brainlab AG (Germany), IBA Worldwide ( Belgium), Accuray Incorporated (United States), VIEWRAY TECHNOLOGIES, INC. (United States), Varian Medical Systems, Inc. (United States), Institut Straumann AG (Switzerland) and Nobel Biocare Services AG (Switzerland). Additionally, following companies can also be profiled that are part of our coverage like CAMLOG Biotechnologies AG (Canada), medentis medical GmbH (Germany), BEGO Medical GmbH (Germany) and Dentsply Sirona (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Treatment Planning Software market by 2026. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Treatment Planning Software market.

In Jan 2019, Philips announced a collaboration with imaging solutions provider MIM Software Inc. to improve radiation therapy treatment planning. With its integrated portfolio of CT and MR imaging systems and intelligent treatment planning software, Philips supports clinicians in making confident therapy decisions. MIM Software provides practical imaging, automation, and data analysis solutions to radiation therapy clinics worldwide.

What Can be Explored with the Treatment Planning Software Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Treatment Planning Software Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Treatment Planning Software
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Treatment Planning Software market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Treatment Planning Software market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Treatment Planning Software Provider, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Auto-contouring Software
  • Multi-modality Software
  • PET/CT Deformable Software
  • DICOM-RT Software
By End User
  • Hospitals
  • Cancer Research Institute
  • Diagnostic & Treatment Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Number of Cancer Patients and a Sizable Expenditure Budget of Them
      • 3.2.2. Rising Demand for the Effective and More Advanced Cancer Treatment
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Workforce to Plan and Operate the Software
    • 3.4. Market Trends
      • 3.4.1. Continues Advancements in the Software
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Treatment Planning Software, by Type, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Treatment Planning Software (Value)
      • 5.2.1. Global Treatment Planning Software by: Type (Value)
        • 5.2.1.1. Auto-contouring Software
        • 5.2.1.2. Multi-modality Software
        • 5.2.1.3. PET/CT Deformable Software
        • 5.2.1.4. DICOM-RT Software
      • 5.2.2. Global Treatment Planning Software by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Cancer Research Institute
        • 5.2.2.3. Diagnostic & Treatment Centers
      • 5.2.3. Global Treatment Planning Software Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Treatment Planning Software (Price)
      • 5.3.1. Global Treatment Planning Software by: Type (Price)
  • 6. Treatment Planning Software: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. DOSIsoft SA (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. MIM Software Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. RaySearch Laboratories (Sweden)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elekta AB (Sweden)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Brainlab AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. IBA Worldwide ( Belgium)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Accuray Incorporated (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. VIEWRAY TECHNOLOGIES, INC. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Varian Medical Systems, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Institut Straumann AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Nobel Biocare Services AG (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Treatment Planning Software Sale, by Type, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Treatment Planning Software (Value)
      • 7.2.1. Global Treatment Planning Software by: Type (Value)
        • 7.2.1.1. Auto-contouring Software
        • 7.2.1.2. Multi-modality Software
        • 7.2.1.3. PET/CT Deformable Software
        • 7.2.1.4. DICOM-RT Software
      • 7.2.2. Global Treatment Planning Software by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Cancer Research Institute
        • 7.2.2.3. Diagnostic & Treatment Centers
      • 7.2.3. Global Treatment Planning Software Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Treatment Planning Software (Price)
      • 7.3.1. Global Treatment Planning Software by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Treatment Planning Software: by Type(USD Million)
  • Table 2. Treatment Planning Software Auto-contouring Software , by Region USD Million (2015-2020)
  • Table 3. Treatment Planning Software Multi-modality Software , by Region USD Million (2015-2020)
  • Table 4. Treatment Planning Software PET/CT Deformable Software , by Region USD Million (2015-2020)
  • Table 5. Treatment Planning Software DICOM-RT Software , by Region USD Million (2015-2020)
  • Table 6. Treatment Planning Software: by End User(USD Million)
  • Table 7. Treatment Planning Software Hospitals , by Region USD Million (2015-2020)
  • Table 8. Treatment Planning Software Cancer Research Institute , by Region USD Million (2015-2020)
  • Table 9. Treatment Planning Software Diagnostic & Treatment Centers , by Region USD Million (2015-2020)
  • Table 10. South America Treatment Planning Software, by Country USD Million (2015-2020)
  • Table 11. South America Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 12. South America Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 13. Brazil Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 14. Brazil Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 15. Argentina Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 16. Argentina Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 17. Rest of South America Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 18. Rest of South America Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 19. Asia Pacific Treatment Planning Software, by Country USD Million (2015-2020)
  • Table 20. Asia Pacific Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 21. Asia Pacific Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 22. China Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 23. China Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 24. Japan Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 25. Japan Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 26. India Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 27. India Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 28. South Korea Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 29. South Korea Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 30. Taiwan Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 31. Taiwan Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 32. Australia Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 33. Australia Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 36. Europe Treatment Planning Software, by Country USD Million (2015-2020)
  • Table 37. Europe Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 38. Europe Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 39. Germany Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 40. Germany Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 41. France Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 42. France Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 43. Italy Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 44. Italy Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 45. United Kingdom Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 46. United Kingdom Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 47. Netherlands Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 48. Netherlands Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 49. Rest of Europe Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 50. Rest of Europe Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 51. MEA Treatment Planning Software, by Country USD Million (2015-2020)
  • Table 52. MEA Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 53. MEA Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 54. Middle East Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 55. Middle East Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 56. Africa Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 57. Africa Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 58. North America Treatment Planning Software, by Country USD Million (2015-2020)
  • Table 59. North America Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 60. North America Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 61. United States Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 62. United States Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 63. Canada Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 64. Canada Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 65. Mexico Treatment Planning Software, by Type USD Million (2015-2020)
  • Table 66. Mexico Treatment Planning Software, by End User USD Million (2015-2020)
  • Table 67. Treatment Planning Software: by Type(USD/Units)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Treatment Planning Software: by Type(USD Million)
  • Table 80. Treatment Planning Software Auto-contouring Software , by Region USD Million (2021-2026)
  • Table 81. Treatment Planning Software Multi-modality Software , by Region USD Million (2021-2026)
  • Table 82. Treatment Planning Software PET/CT Deformable Software , by Region USD Million (2021-2026)
  • Table 83. Treatment Planning Software DICOM-RT Software , by Region USD Million (2021-2026)
  • Table 84. Treatment Planning Software: by End User(USD Million)
  • Table 85. Treatment Planning Software Hospitals , by Region USD Million (2021-2026)
  • Table 86. Treatment Planning Software Cancer Research Institute , by Region USD Million (2021-2026)
  • Table 87. Treatment Planning Software Diagnostic & Treatment Centers , by Region USD Million (2021-2026)
  • Table 88. South America Treatment Planning Software, by Country USD Million (2021-2026)
  • Table 89. South America Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 90. South America Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 91. Brazil Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 92. Brazil Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 93. Argentina Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 94. Argentina Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 95. Rest of South America Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 96. Rest of South America Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 97. Asia Pacific Treatment Planning Software, by Country USD Million (2021-2026)
  • Table 98. Asia Pacific Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 99. Asia Pacific Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 100. China Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 101. China Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 102. Japan Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 103. Japan Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 104. India Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 105. India Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 106. South Korea Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 107. South Korea Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 108. Taiwan Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 109. Taiwan Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 110. Australia Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 111. Australia Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 112. Rest of Asia-Pacific Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 113. Rest of Asia-Pacific Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 114. Europe Treatment Planning Software, by Country USD Million (2021-2026)
  • Table 115. Europe Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 116. Europe Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 117. Germany Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 118. Germany Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 119. France Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 120. France Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 121. Italy Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 122. Italy Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 123. United Kingdom Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 124. United Kingdom Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 125. Netherlands Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 126. Netherlands Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 127. Rest of Europe Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 128. Rest of Europe Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 129. MEA Treatment Planning Software, by Country USD Million (2021-2026)
  • Table 130. MEA Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 131. MEA Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 132. Middle East Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 133. Middle East Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 134. Africa Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 135. Africa Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 136. North America Treatment Planning Software, by Country USD Million (2021-2026)
  • Table 137. North America Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 138. North America Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 139. United States Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 140. United States Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 141. Canada Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 142. Canada Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 143. Mexico Treatment Planning Software, by Type USD Million (2021-2026)
  • Table 144. Mexico Treatment Planning Software, by End User USD Million (2021-2026)
  • Table 145. Treatment Planning Software: by Type(USD/Units)
  • Table 146. Research Programs/Design for This Report
  • Table 147. Key Data Information from Secondary Sources
  • Table 148. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Treatment Planning Software: by Type USD Million (2015-2020)
  • Figure 5. Global Treatment Planning Software: by End User USD Million (2015-2020)
  • Figure 6. South America Treatment Planning Software Share (%), by Country
  • Figure 7. Asia Pacific Treatment Planning Software Share (%), by Country
  • Figure 8. Europe Treatment Planning Software Share (%), by Country
  • Figure 9. MEA Treatment Planning Software Share (%), by Country
  • Figure 10. North America Treatment Planning Software Share (%), by Country
  • Figure 11. Global Treatment Planning Software: by Type USD/Units (2015-2020)
  • Figure 12. Global Treatment Planning Software share by Players 2020 (%)
  • Figure 13. Global Treatment Planning Software share by Players (Top 3) 2020(%)
  • Figure 14. Global Treatment Planning Software share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. DOSIsoft SA (France) Revenue, Net Income and Gross profit
  • Figure 17. DOSIsoft SA (France) Revenue: by Geography 2020
  • Figure 18. MIM Software Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. MIM Software Inc. (United States) Revenue: by Geography 2020
  • Figure 20. RaySearch Laboratories (Sweden) Revenue, Net Income and Gross profit
  • Figure 21. RaySearch Laboratories (Sweden) Revenue: by Geography 2020
  • Figure 22. Elekta AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 23. Elekta AB (Sweden) Revenue: by Geography 2020
  • Figure 24. Brainlab AG (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Brainlab AG (Germany) Revenue: by Geography 2020
  • Figure 26. IBA Worldwide ( Belgium) Revenue, Net Income and Gross profit
  • Figure 27. IBA Worldwide ( Belgium) Revenue: by Geography 2020
  • Figure 28. Accuray Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 29. Accuray Incorporated (United States) Revenue: by Geography 2020
  • Figure 30. VIEWRAY TECHNOLOGIES, INC. (United States) Revenue, Net Income and Gross profit
  • Figure 31. VIEWRAY TECHNOLOGIES, INC. (United States) Revenue: by Geography 2020
  • Figure 32. Varian Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Varian Medical Systems, Inc. (United States) Revenue: by Geography 2020
  • Figure 34. Institut Straumann AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Institut Straumann AG (Switzerland) Revenue: by Geography 2020
  • Figure 36. Nobel Biocare Services AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Nobel Biocare Services AG (Switzerland) Revenue: by Geography 2020
  • Figure 38. Global Treatment Planning Software: by Type USD Million (2021-2026)
  • Figure 39. Global Treatment Planning Software: by End User USD Million (2021-2026)
  • Figure 40. South America Treatment Planning Software Share (%), by Country
  • Figure 41. Asia Pacific Treatment Planning Software Share (%), by Country
  • Figure 42. Europe Treatment Planning Software Share (%), by Country
  • Figure 43. MEA Treatment Planning Software Share (%), by Country
  • Figure 44. North America Treatment Planning Software Share (%), by Country
  • Figure 45. Global Treatment Planning Software: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • DOSIsoft SA (France)
  • MIM Software Inc. (United States)
  • RaySearch Laboratories (Sweden)
  • Elekta AB (Sweden)
  • Brainlab AG (Germany)
  • IBA Worldwide ( Belgium)
  • Accuray Incorporated (United States)
  • VIEWRAY TECHNOLOGIES, INC. (United States)
  • Varian Medical Systems, Inc. (United States)
  • Institut Straumann AG (Switzerland)
  • Nobel Biocare Services AG (Switzerland)
Additional players considered in the study are as follows:
CAMLOG Biotechnologies AG (Canada) , medentis medical GmbH (Germany) , BEGO Medical GmbH (Germany) , Dentsply Sirona (United States)
Select User Access Type

Key Highlights of Report


May 2021 233 Pages 66 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Treatment Planning Software Market Quantitative research analysis
Global Treatment Planning Software Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Treatment Planning Software Market Report?

Have a Query? Click Here

Other Related Reports

Cloud-Seeding System Comprehensive Study by Application (Fog Dispersal, Snow Augmentation/Reduction, Rain Enhancement, Hail Suppression, Others), Cloud Temperature (Cold Clouds, Warm Clouds), Mode of...
$ 3650
Computational medicine & drug discovery software Comprehensive Study by Type (Database, Software, Others), Application (Computational Physiological Medicine, Drug Discovery and Development, Medical I...
$ 3750
Network File System Comprehensive Study by Application (SMEs, Large Enterprises), Version (NFSv3, NFSv4, NFSv4.1, NFSv4.2), Features (Tiered File System, Disaster Recovery, Automated Deduplication, O...
$ 3500
Website Builder Tool Comprehensive Study by Type (PC Website Builders, Mobile Website Builders, Others), Application (Small and Mid-Sized Businesses, Personal Website, Portfolios, Design & Arts, E-Co...
$ 3650
Mobile Threat Management Security Software Comprehensive Study by Type (Authentication, Application Security, Device Security), Application (Individual User, Telecommunication and IT, Government and ...
$ 3650
Retail Warehouse Management Systems Comprehensive Study by Function (Inventory Management, Order Management, On-Demand Barcoding/Serial Tracking, Workforce Management, Others), Enterprise Size (Small...
$ 3750